2 completed, 1 terminated. 2 Not applicable, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 2 | Completed 1, Terminated 1 |
| Phase 4 | 1 | Completed 1 |
Follow Cationorm: new trials by email Literature Review of Cationorm trials Research Report on Cationorm
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluate The Improvement In Symptoms Of Patients Using Cationorm After Pterygium Surgery Cationorm single-dose eye drop, Artificial tear eye drop - Ocular Discomfort | Phase 4 | Completed | Nguyen Viet Giap | 100 | 2022-06-15 | 2025-08-06 |
| Evaluation of MAF-1217 in Patients With DED MAF1217, Cationorm - Evaporative Dry Eye Disease | Not applicable | Completed | VISUfarma SpA | 72 | 2018-11-27 | 2019-07-15 |
| REMOGEN® Omega Versus Cationorm® in the Treatment of Patients Suffering From Dry Eye Remogen, Cationorm - Dry Eye | Not applicable | Terminated | TRB Chemedica | 26 | 2018-03-30 | 2020-04-20 |
Nguyen Viet Giap (1) · TRB Chemedica (1) · VISUfarma SpA (1)
France (1) · Italy (1) · Vietnam (1)
Christophe Baudouin, MD, PhD (1)